ISPOR’s annual meeting in Montreal this May was packed with opportunities to explore the latest trends, insights, and ...

The Medscape Education Global team will be travelling to Amsterdam for the HLTH Europe 2025 conference to showcase the power ...

BioNTech’s BNT327 is being evaluated in multiple clinical trials, including phase 3 studies in first-line lung cancer ...

AstraZeneca (AZ) has announced that a wider range of chronic kidney disease (CKD) patients across England and Wales will be ...

The phase 3 IMforte study randomised adults with extensive-stage SCLC to receive Roche’s PD-L1 inhibitor Tecentriq ...

NHS frameworks, such as Patient and Public Involvement, have demonstrated the value of integrating patient perspectives into ...

We know that engaging with HCPs is incredibly valuable for medical education, with 48% of HCPs from a McKinsey Pharma ...